Skip to main content
Caplight Logo









Onselex Pharmaceuticals

Onselex Pharmaceuticals

Private
New York City, New YorkHealthcare & Life Scienceshttps://onselex.com/

Last Round

VC Round

Aug 25, 2020

Total Funding Raised

$1.3M

Company Overview

Onselex Pharmaceuticals is a biotechnology company that develops nanoparticle-based oncology medications designed to improve the therapeutic index of established cancer drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanomedicinedrug deliveryoncologytargeted therapynanoparticle technologybiotechdrug developmentclinical trialsprecision medicinechemotherapydrug licensingbiopharmadrug delivery platformpreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Onselex Pharmaceuticals Comparables

Compare Onselex Pharmaceuticals with similar companies based on industry and business-model similarity.

Onselex Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cession Oncology
85%
NanOlogy, LLC
83%
Nanobots Therapeutics
75%

Onselex Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 25, 2020
SeedMar 19, 2020

Key People

Founding team and executive leadership

Ernie Shin

Founder & CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2020

    $2.17M round raised.

Onselex Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Onselex Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Onselex Pharmaceuticals's valuation, stock price, and market status.

Is Onselex Pharmaceuticals a public or private company?

Onselex Pharmaceuticals is a private company.

What is the current stock price of Onselex Pharmaceuticals?

Onselex Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Onselex Pharmaceuticals worth (valuation)?

Valuation information for Onselex Pharmaceuticals is not publicly available.

Can I buy Onselex Pharmaceuticals stock?

Onselex Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Onselex Pharmaceuticals's last funding round?

Onselex Pharmaceuticals's most recent funding round was VC Round on August 25, 2020.

Who are the main investors in Onselex Pharmaceuticals?

Investor information for Onselex Pharmaceuticals is not publicly disclosed.

Will Onselex Pharmaceuticals IPO soon?

No public IPO plans have been announced for Onselex Pharmaceuticals.

How can I track Onselex Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Onselex Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range4
Year Founded2018
Last FundingAug 25, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?